High prevalence of anxiety and depression in patients with primary open-angle glaucoma

Fumihiko Mabuchi, Kimio Yoshimura, Kenji Kashiwagi, Kunihiko Shioe, Zentaro Yamagata, Shigenobu Kanba, Hiroyuki Iijima, Shigeo Tsukahara

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

PURPOSE: To assess anxiety and depression in patients with primary open-angle glaucoma (POAG). DESIGN: Multicenter prospective case-control study. PARTICIPANTS: Two hundred thirty patients with POAG and 230 sex-matched and age-matched reference subjects with no chronic ocular conditions except cataracts. INTERVENTION: Anxiety and depression were evaluated using Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of 2 subscales with ranges of 0 to 21, representing anxiety (HADS-A) and depression (HADS-D). MAIN OUTCOME MEASURE: The prevalence of POAG patients with anxiety (a score of more than 10 on the HADS-A) or depression (a score of more than 10 on the HADS-D) was compared with that in the reference subjects. The prevalence of patients with depression was compared between the POAG patients with and without current β-blocker eye drops. RESULTS: The prevalence (13.0%) of POAG patients with anxiety was significantly higher (P=0.030) than in the reference subjects (7.0%). The prevalence (10.9%) of POAG patients with depression was significantly higher (P=0.026) than in the reference subjects (5.2%). Between the POAG patients with and without β-blocker eye-drops, no significant difference (P=0.93) in the prevalence of depression was noted. CONCLUSIONS: POAG was related to anxiety and depression. No significant relationship between the use of β-blocker eye-drops and depression was noted.

Original languageEnglish
Pages (from-to)552-557
Number of pages6
JournalJournal of Glaucoma
Volume17
Issue number7
DOIs
Publication statusPublished - Oct 1 2008

Fingerprint

Anxiety
Depression
Ophthalmic Solutions
Primary Open Angle Glaucoma
Cataract
Case-Control Studies
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Ophthalmology

Cite this

Mabuchi, F., Yoshimura, K., Kashiwagi, K., Shioe, K., Yamagata, Z., Kanba, S., ... Tsukahara, S. (2008). High prevalence of anxiety and depression in patients with primary open-angle glaucoma. Journal of Glaucoma, 17(7), 552-557. https://doi.org/10.1097/IJG.0b013e31816299d4

High prevalence of anxiety and depression in patients with primary open-angle glaucoma. / Mabuchi, Fumihiko; Yoshimura, Kimio; Kashiwagi, Kenji; Shioe, Kunihiko; Yamagata, Zentaro; Kanba, Shigenobu; Iijima, Hiroyuki; Tsukahara, Shigeo.

In: Journal of Glaucoma, Vol. 17, No. 7, 01.10.2008, p. 552-557.

Research output: Contribution to journalArticle

Mabuchi, F, Yoshimura, K, Kashiwagi, K, Shioe, K, Yamagata, Z, Kanba, S, Iijima, H & Tsukahara, S 2008, 'High prevalence of anxiety and depression in patients with primary open-angle glaucoma', Journal of Glaucoma, vol. 17, no. 7, pp. 552-557. https://doi.org/10.1097/IJG.0b013e31816299d4
Mabuchi F, Yoshimura K, Kashiwagi K, Shioe K, Yamagata Z, Kanba S et al. High prevalence of anxiety and depression in patients with primary open-angle glaucoma. Journal of Glaucoma. 2008 Oct 1;17(7):552-557. https://doi.org/10.1097/IJG.0b013e31816299d4
Mabuchi, Fumihiko ; Yoshimura, Kimio ; Kashiwagi, Kenji ; Shioe, Kunihiko ; Yamagata, Zentaro ; Kanba, Shigenobu ; Iijima, Hiroyuki ; Tsukahara, Shigeo. / High prevalence of anxiety and depression in patients with primary open-angle glaucoma. In: Journal of Glaucoma. 2008 ; Vol. 17, No. 7. pp. 552-557.
@article{896576f4d6a74a7d978b534ffdab6d28,
title = "High prevalence of anxiety and depression in patients with primary open-angle glaucoma",
abstract = "PURPOSE: To assess anxiety and depression in patients with primary open-angle glaucoma (POAG). DESIGN: Multicenter prospective case-control study. PARTICIPANTS: Two hundred thirty patients with POAG and 230 sex-matched and age-matched reference subjects with no chronic ocular conditions except cataracts. INTERVENTION: Anxiety and depression were evaluated using Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of 2 subscales with ranges of 0 to 21, representing anxiety (HADS-A) and depression (HADS-D). MAIN OUTCOME MEASURE: The prevalence of POAG patients with anxiety (a score of more than 10 on the HADS-A) or depression (a score of more than 10 on the HADS-D) was compared with that in the reference subjects. The prevalence of patients with depression was compared between the POAG patients with and without current β-blocker eye drops. RESULTS: The prevalence (13.0{\%}) of POAG patients with anxiety was significantly higher (P=0.030) than in the reference subjects (7.0{\%}). The prevalence (10.9{\%}) of POAG patients with depression was significantly higher (P=0.026) than in the reference subjects (5.2{\%}). Between the POAG patients with and without β-blocker eye-drops, no significant difference (P=0.93) in the prevalence of depression was noted. CONCLUSIONS: POAG was related to anxiety and depression. No significant relationship between the use of β-blocker eye-drops and depression was noted.",
author = "Fumihiko Mabuchi and Kimio Yoshimura and Kenji Kashiwagi and Kunihiko Shioe and Zentaro Yamagata and Shigenobu Kanba and Hiroyuki Iijima and Shigeo Tsukahara",
year = "2008",
month = "10",
day = "1",
doi = "10.1097/IJG.0b013e31816299d4",
language = "English",
volume = "17",
pages = "552--557",
journal = "Journal of Glaucoma",
issn = "1057-0829",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - High prevalence of anxiety and depression in patients with primary open-angle glaucoma

AU - Mabuchi, Fumihiko

AU - Yoshimura, Kimio

AU - Kashiwagi, Kenji

AU - Shioe, Kunihiko

AU - Yamagata, Zentaro

AU - Kanba, Shigenobu

AU - Iijima, Hiroyuki

AU - Tsukahara, Shigeo

PY - 2008/10/1

Y1 - 2008/10/1

N2 - PURPOSE: To assess anxiety and depression in patients with primary open-angle glaucoma (POAG). DESIGN: Multicenter prospective case-control study. PARTICIPANTS: Two hundred thirty patients with POAG and 230 sex-matched and age-matched reference subjects with no chronic ocular conditions except cataracts. INTERVENTION: Anxiety and depression were evaluated using Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of 2 subscales with ranges of 0 to 21, representing anxiety (HADS-A) and depression (HADS-D). MAIN OUTCOME MEASURE: The prevalence of POAG patients with anxiety (a score of more than 10 on the HADS-A) or depression (a score of more than 10 on the HADS-D) was compared with that in the reference subjects. The prevalence of patients with depression was compared between the POAG patients with and without current β-blocker eye drops. RESULTS: The prevalence (13.0%) of POAG patients with anxiety was significantly higher (P=0.030) than in the reference subjects (7.0%). The prevalence (10.9%) of POAG patients with depression was significantly higher (P=0.026) than in the reference subjects (5.2%). Between the POAG patients with and without β-blocker eye-drops, no significant difference (P=0.93) in the prevalence of depression was noted. CONCLUSIONS: POAG was related to anxiety and depression. No significant relationship between the use of β-blocker eye-drops and depression was noted.

AB - PURPOSE: To assess anxiety and depression in patients with primary open-angle glaucoma (POAG). DESIGN: Multicenter prospective case-control study. PARTICIPANTS: Two hundred thirty patients with POAG and 230 sex-matched and age-matched reference subjects with no chronic ocular conditions except cataracts. INTERVENTION: Anxiety and depression were evaluated using Hospital Anxiety and Depression Scale (HADS) questionnaire, which consists of 2 subscales with ranges of 0 to 21, representing anxiety (HADS-A) and depression (HADS-D). MAIN OUTCOME MEASURE: The prevalence of POAG patients with anxiety (a score of more than 10 on the HADS-A) or depression (a score of more than 10 on the HADS-D) was compared with that in the reference subjects. The prevalence of patients with depression was compared between the POAG patients with and without current β-blocker eye drops. RESULTS: The prevalence (13.0%) of POAG patients with anxiety was significantly higher (P=0.030) than in the reference subjects (7.0%). The prevalence (10.9%) of POAG patients with depression was significantly higher (P=0.026) than in the reference subjects (5.2%). Between the POAG patients with and without β-blocker eye-drops, no significant difference (P=0.93) in the prevalence of depression was noted. CONCLUSIONS: POAG was related to anxiety and depression. No significant relationship between the use of β-blocker eye-drops and depression was noted.

UR - http://www.scopus.com/inward/record.url?scp=58149339947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149339947&partnerID=8YFLogxK

U2 - 10.1097/IJG.0b013e31816299d4

DO - 10.1097/IJG.0b013e31816299d4

M3 - Article

C2 - 18854732

AN - SCOPUS:58149339947

VL - 17

SP - 552

EP - 557

JO - Journal of Glaucoma

JF - Journal of Glaucoma

SN - 1057-0829

IS - 7

ER -